ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
About this item
Full title
Author / Creator
Publisher
Germany: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Germany: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Lung cancer is the leading cause of cancer-related deaths with 1.8 million new cases each year and poor 5-year prognosis. Promoter hypermethylation of tumour suppressors leads to their inactivation and thereby can promote cancer development and progression.
In this study, we analysed ZAR1 (zygote arrest 1), which has been said to be a maternal-e...
Alternative Titles
Full title
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b953bc56758d461faa9e60f8787adfd2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b953bc56758d461faa9e60f8787adfd2
Other Identifiers
ISSN
1868-7075,1868-7083
E-ISSN
1868-7083,1868-7075
DOI
10.1186/s13148-017-0360-4
